Lanzhou Foci Pharmaceutical Co Ltd Net Asset Quality Index
Lanzhou Foci Pharmaceutical Co Ltd net asset quality index. Lanzhou Foci Pharmaceutical Co Ltd (002644) has a Net Asset Quality Index of 73.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.52 Billion minus total liabilities of CN¥678.01 Million yields net assets of CN¥1.85 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 002644 net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Lanzhou Foci Pharmaceutical Co Ltd (2007–2024)
Net asset quality index of Lanzhou Foci Pharmaceutical Co Ltd from 2007 to 2024. This chart shows how Lanzhou Foci Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 18 annual periods from 2007 to 2024. As of September 2025, the index stands at 73.1%, representing net assets of CN¥1.85 Billion against total assets of CN¥2.52 Billion CNY. Check Lanzhou Foci Pharmaceutical Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Lanzhou Foci Pharmaceutical Co Ltd Net Asset Quality Index by Year (2007–2024)
Lanzhou Foci Pharmaceutical Co Ltd net asset quality index by year from 2007 to 2024. The table below presents the year-by-year Net Asset Quality Index for Lanzhou Foci Pharmaceutical Co Ltd from 2007 to 2024, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Lanzhou Foci Pharmaceutical Co Ltd.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 73.5% | CN¥1.81 Billion | CN¥2.47 Billion | CN¥654.81 Million | ▲ +3.5 pp |
| 2023 | 70.0% | CN¥1.77 Billion | CN¥2.53 Billion | CN¥759.67 Million | ▲ +2.9 pp |
| 2022 | 67.0% | CN¥1.73 Billion | CN¥2.59 Billion | CN¥852.60 Million | ▼ -2.2 pp |
| 2021 | 69.2% | CN¥1.63 Billion | CN¥2.35 Billion | CN¥724.59 Million | ▲ +2.7 pp |
| 2020 | 66.5% | CN¥1.59 Billion | CN¥2.39 Billion | CN¥800.08 Million | ▲ +3.7 pp |
| 2019 | 62.8% | CN¥1.51 Billion | CN¥2.40 Billion | CN¥893.78 Million | ▲ +5.7 pp |
| 2018 | 57.1% | CN¥1.44 Billion | CN¥2.52 Billion | CN¥1.08 Billion | ▼ -0.8 pp |
| 2017 | 57.8% | CN¥1.36 Billion | CN¥2.35 Billion | CN¥990.68 Million | ▼ -5.5 pp |
| 2016 | 63.4% | CN¥1.29 Billion | CN¥2.04 Billion | CN¥746.13 Million | ▼ -27.2 pp |
| 2015 | 90.5% | CN¥1.23 Billion | CN¥1.36 Billion | CN¥128.77 Million | ▲ +20.3 pp |
| 2014 | 70.2% | CN¥735.22 Million | CN¥1.05 Billion | CN¥311.40 Million | ▼ -7.6 pp |
| 2013 | 77.9% | CN¥703.37 Million | CN¥903.08 Million | CN¥199.70 Million | ▼ -4.2 pp |
| 2012 | 82.1% | CN¥675.53 Million | CN¥822.91 Million | CN¥147.38 Million | ▲ +3.9 pp |
| 2011 | 78.2% | CN¥648.08 Million | CN¥829.23 Million | CN¥181.14 Million | ▲ +6.6 pp |
| 2010 | 71.6% | CN¥326.46 Million | CN¥456.16 Million | CN¥129.70 Million | ▲ +11.6 pp |
| 2009 | 59.9% | CN¥252.96 Million | CN¥422.05 Million | CN¥169.09 Million | ▲ +5.8 pp |
| 2008 | 54.1% | CN¥216.81 Million | CN¥400.52 Million | CN¥183.70 Million | ▼ -0.1 pp |
| 2007 | 54.2% | CN¥195.20 Million | CN¥359.92 Million | CN¥164.72 Million | — |